BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  New Research Finds About Half of Parents Use Cell Phones While Driving with Young Children in the Car

  Study of Adults Across the U.S. Also Revealed Risky Behaviors Associated with Distracted Driving

  July 12, 2018

   · 

  5 min read
• AGC to Expand GMP-Compliant Synthetic Pharmaceutical Intermediate and Active Ingredient Production Capacity Tenfold

  Broadened CDMO Business Will Cover Commercial New Drugs As Well As in Development Stage of Ones

  July 12, 2018

   · 

  2 min read
• Deals

  ViaDerma Provides an Update to Shareholders via a Letter from the CEOThe Company is also in early stage discussions to sell its product on TV

  ViaDerma, Inc. is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the Company’s website, www.viadermalicensing.com. (Link to CEO Letter)

  July 12, 2018

   · 

  1 min read
• Policy

  Gilead Receives Approval in Canada for BIKTARVY™ (bictegravir, emtricitabine, tenofovir alafenamide) for the Treatment of HIV-1 Infection

  In clinical trials, BIKTARVY demonstrated high efficacy, and a high barrier to resistance

  July 12, 2018

   · 

  7 min read
• Pharm Country

  Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community

  Galaxies of Hope offers a unique digital experience that engages users through the art of visual storytelling to connect with others to understand NET cancer

  July 12, 2018

   · 

  3 min read
• Policy

  Iowa Department of Public Health Awards License to Acreage Holdings

  Nation’s Largest Cannabis Company Gains State’s Second License to Manufacture Cannabis Oil

  July 12, 2018

   · 

  2 min read
• Business

  Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

  SkinCure Provides Turnkey Solution for Sensus’ SRT-100 Vision™, Aimed at Dermatology Community

  July 12, 2018

   · 

  8 min read
• Drug Development

  Oyster Point Pharma Announces Positive Results from Phase 2 Clinical Trial of the Company’s Investigational Treatment for Dry Eye Disease

  Oyster Point Pharma, Inc., today announced results from the PEARL study, a Phase 2b clinical trial evaluating the company’s novel therapy for the treatment of Dry Eye Disease (DED).

  July 12, 2018

   · 

  5 min read
• Business

  Incyte to Report Second Quarter 2018 Financial Results

  Incyte Corporation announced that it has scheduled its second quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 31, 2018.

  July 12, 2018

   · 

  1 min read
• Drug Development

  Seattle Genetics Announces First Patient Dosed in Phase 2 innovaTV 207 Trial Evaluating Tisotumab Vedotin in Multiple Solid Tumors

  Seattle Genetics, Inc. (Nasdaq:SGEN) today announced dosing of the first patient in the phase 2 innovaTV 207 clinical trial.

  July 12, 2018

   · 

  5 min read